Loading…
The relationship between interleukin-6 and functional connectivity in methamphetamine users
•Interleukin 6 (IL-6) levels are higher in methamphetamine (MA) users than in controls.•Relationships between functional connectivity (FC) and IL-6 differ by group.•Striatolimbic FC and IL-6: positively related in MA users but negatively in controls.•Corticostriatal FC and IL-6: unrelated in control...
Saved in:
Published in: | Neuroscience letters 2018-06, Vol.677, p.49-54 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •Interleukin 6 (IL-6) levels are higher in methamphetamine (MA) users than in controls.•Relationships between functional connectivity (FC) and IL-6 differ by group.•Striatolimbic FC and IL-6: positively related in MA users but negatively in controls.•Corticostriatal FC and IL-6: unrelated in controls and negatively related in MA users.
Methamphetamine (MA) causes an increase in pro-inflammatory cytokines in animal models and in humans. Resulting activation of microglia and neuro-inflammation could, via effects on reward networks, mediate behavioral characteristics of addiction. We examined the relationship between interleukin-6 (IL-6) and corticolimbic and striatolimbic resting-state functional connectivity (RSFC). Thirty adults diagnosed with MA dependence and 20 control subjects underwent a resting-state functional magnetic resonance imaging (fMRI) scan and gave a blood sample for determination of plasma IL-6 levels. Seed-based RSFC analyses were performed to examine the interactive effect of group and IL-6 on ventral striatal and prefrontal connectivity. Within the MA group, IL-6 levels were positively related to striatolimbic RSFC but negatively related to corticostriatal RSFC. Our findings with IL-6 support the idea that inflammation may at least partly mediate the link among MA use disorder, RSFC, and behavior, possibly via effects on mesolimbic and mesocortical dopaminergic systems. |
---|---|
ISSN: | 0304-3940 1872-7972 |
DOI: | 10.1016/j.neulet.2018.04.037 |